The Wait Is Over. Blue Chips Are Back
Three impressive ways to benefit from the revival of large, growing companies. By Katy Marquardt
Pssst. Here's a tip you should take if you don't want to leave money on the table: Get to know large companies. After spending most of this decade in the doghouse, the big guys are off and running. In the first 9½ months of 2007, funds that invest in large, fast-growing companies returned 18%, on average. That beats just about every other category. Meanwhile, small-company value funds, which topped all others for years, are also-rans, with an average gain of just 4%.
Chances are good that large-company stocks will lead the pack for several years. The Kiplinger 25 includes two excellent big-company funds: Marsico 21st Century (symbol MXXIX), up 24% in 2007 to October 15, and T. Rowe Price Growth Stock (PRGFX), up 16%. We thought you would like to know about three others that just missed the cut but are nonetheless fine funds.
A high-octane choice is Fidelity Growth Discovery. Although Jason Weiner only recently took over as manager, in February 2007, he is no stranger to this fund: He actually ran it in its early years, when it was called Contrafund II. He has also run several other diversified funds at Fidelity, as well as a couple of sector funds.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Weiner, who describes his strategy as "extremely flexible," invests in companies of any size, although he leans heavily toward the market's giants. He can also hunt abroad for firms with the best earnings-growth potential. Foreign names recently accounted for one-fourth of the $753-million fund's assets. Weiner is bullish on tech, which represented 40% of assets, and "global growers," such as Schlumberger. This year to October 15, Growth Discovery (FDSVX) returned 30%.
Another aggressive fund is Excelsior Large Cap Growth. Run by Tom Galvin, a former Wall Street strategist, the $875-million fund (UMLGX) holds only 25 to 30 stocks. Such concentration adds risk but helps boost returns when the manager is right more often than he is wrong. Moreover, Galvin, like Weiner, also holds about 40% of assets in tech stocks. So far this year, Galvin has been on a roll -- his fund gained 26% through mid October. Over the past three years, Excelsior gained an annualized 20%, beating the typical fund that focuses on large, growing companies by an average of six percentage points per year.
As befits a former strategist, Galvin assesses the big picture when shaping his portfolio. For example, in health care, he favors Allergan, the maker of Botox, and orthopedics-device firm Zimmer (see Health Stocks on the Mend). Says Galvin: "Some people say, 'Don't fight the Fed.' We say, 'Don't fight demographics.'" Beyond that, he looks for companies that have little debt on their books and are capable of generating annual earnings growth of at least 12%.
A somewhat stodgier pick is Aston/Montag & Caldwell Growth, which favors slower-growing but steadier giants. Ron Canakaris, who has steered the fund since its inception in 1994, seeks high-quality companies that can generate earnings gains of at least 10% per year. But he buys a stock only if it's selling at least 20% below his calculation of the company's true worth.
Canakaris focuses on mega-caps, or companies with the largest market capitalizations. Shares of the biggest companies have lagged for most of the decade, so the $1.9-billion fund (MCGFX) trailed its peers in each calendar year between 2003 and 2006. Over the past decade, though, the fund's annualized return of 5% matched the typical large-company growth fund, and it did so with 20% less volatility. So far this year, Montag & Caldwell is up 22%.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
-
5 Steps to Turn Your Nest Egg into a Retirement Paycheck
Sponsored Sponsored Content by Sensible Money
By Sponsored Content Published
-
What’s Happening With Trump, Elon, Tesla, and the EV Tax Credit?
Tax Credits There's a lot of chatter about the President-elect's plans to eliminate the electric vehicle tax credit. Here's what you need to know.
By Kelley R. Taylor Published
-
Best Banks for High-Net-Worth Clients 2024
wealth management These banks welcome customers who keep high balances in deposit and investment accounts, showering them with fee breaks and access to financial-planning services.
By Lisa Gerstner Last updated
-
Stock Market Holidays in 2024: NYSE, NASDAQ and Wall Street Holidays
Markets When are the stock market holidays? Here, we look at which days the NYSE, Nasdaq and bond markets are off in 2024.
By Kyle Woodley Last updated
-
Stock Market Trading Hours: What Time Is the Stock Market Open Today?
Markets When does the market open? While the stock market does have regular hours, trading doesn't necessarily stop when the major exchanges close.
By Michael DeSenne Last updated
-
Bogleheads Stay the Course
Bears and market volatility don’t scare these die-hard Vanguard investors.
By Kim Clark Published
-
The Current I-Bond Rate Until May Is Mildly Attractive. Here's Why.
Investing for Income The current I-bond rate is active until November 2024 and presents an attractive value, if not as attractive as in the recent past.
By David Muhlbaum Last updated
-
What Are I-Bonds? Inflation Made Them Popular. What Now?
savings bonds Inflation has made Series I savings bonds, known as I-bonds, enormously popular with risk-averse investors. So how do they work?
By Lisa Gerstner Last updated
-
This New Sustainable ETF’s Pitch? Give Back Profits.
investing Newday’s ETF partners with UNICEF and other groups.
By Ellen Kennedy Published
-
As the Market Falls, New Retirees Need a Plan
retirement If you’re in the early stages of your retirement, you’re likely in a rough spot watching your portfolio shrink. We have some strategies to make the best of things.
By David Rodeck Published